This article requires a subscription to view the full text. You may purchase access to this article or login to access your subscription using the links below.
Abstract
A recent study involving patients with acute myeloid leukemia or myelodysplastic syndromes finds that whole-genome sequencing can detect more chromosomal alterations than traditional cytogenetics. In addition, whole-genome sequencing could improve the accuracy of prognoses. The study also found that the technique was faster than cytogenetics with a similar cost.
- ©2021 American Association for Cancer Research.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
This OnlineFirst version was published on March 26, 2021
doi: 10.1158/2159-8290.CD-NB2021-0328
WGS Outshines Cytogenetics in Myeloid Cancers
Jump to section
Advertisement